Abstract | IMPORTANCE OF THE FIELD:
Asparaginase is a prominent component of pediatric and adolescent treatment for acute lymphoblastic leukemia. These treatment regimens are now being employed in adults. Knowledge of the efficacy and toxicity of asparaginase preparations is essential when using these treatments. AREAS COVERED BY THIS REVIEW: The search terms used were asparaginase, leukemia, pegylated, oncaspar, adolescent and young adult. Literature was searched in Pubmed/Medline with no limitations on year of publication. Abstracts from the American Society of Hematology meetings and the American Society of Clinical Oncology were searched from 2004 - 2008 using the same terms. WHAT THE READER WILL GAIN: TAKE HOME MESSAGE:
|
Authors | Michael Rytting |
Journal | Expert opinion on biological therapy
(Expert Opin Biol Ther)
Vol. 10
Issue 5
Pg. 833-9
(May 2010)
ISSN: 1744-7682 [Electronic] England |
PMID | 20345338
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antineoplastic Agents
- Polyethylene Glycols
- pegaspargase
- Asparaginase
|
Topics |
- Adolescent
- Adult
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Asparaginase
(adverse effects, therapeutic use)
- Drug Hypersensitivity
(etiology)
- Humans
- Polyethylene Glycols
(adverse effects, therapeutic use)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy)
- Treatment Outcome
- Young Adult
|